SOPHiA GENETICS SA Logo

SOPHiA GENETICS SA (90B)

XSTU

Currency in EUR
7.30
+0.10 (+1.39%)

Closed

Aug 25, 2026

Day's Range

7.10
7.50

52 wk Range

2.62
7.50

Overview - 90B - SOPHiA GENETICS SA

Key Statistics

Valuation

Enterprise Value

485.62M

P/E (Trailing)

‪-6.11‬

PEG Ratio

‪0.67‬

Price / Sales (TTM)

‪7.11‬

Price / Book

‪8.61‬

EV / EBITDA

‪-7.90‬

Profitability

Gross Margin

‪64.61%‬

Profit Margin

‪-93.86%‬

Operating Margin

‪-86.02%‬

Return on Assets

‪-24.51%‬

Return on Equity

‪-101.21%‬

Ownership

Shares Outstanding

83.89M

Float

65.31M

Held by Insiders

‪6.83%‬

Held by Institutions

‪62.23%‬

Price stats

Beta

‪0.92‬

50-Day Avg

‪5.33‬

200-Day Avg

‪4.42‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 90B - SOPHiA GENETICS SA

Peers - 90B - SOPHiA GENETICS SA

Peer Comparison

Compared with companies in Health Information Services listed on XSTU.

Profile Summary - 90B - SOPHiA GENETICS SA

About

Sophia Genetics SA is a global leader in data-driven medicine focused on enabling healthcare institutions to leverage artificial intelligence and data analytics to enhance clinical diagnosis. The company's main purpose is to democratize data-driven medicine, making genomic and other types of patient data insights…

SectorHealthcare
IndustryHealth Information Services
Employees415
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.